Skip to content

NAGE NAGE Analytical Reference Standards and Services segment — R&D

Other segment segments

Consumer Products segment
$733K+13.6%
Pharmaceuticals segment
$368K
Ingredients segment
$280K+14.3%

Similar metrics at other companies

Ascent Industries Co. logo
ACNTSpecialty Chemicals — R&D
$63K
Ginkgo Bioworks logo
DNAReportable Segment — R&D
$30.11M-38.1%
Ouster logo
OUSTReportable Segment — R&D
$16.08M+7.3%
Indivior Pharmaceuticals, Inc.
 logo
INDVReportable Segment — R&D
$16M-27.3%
SANUWAVE Health, Inc. logo
SNWVReportable Segment — R&D
$660K+217%
Arvinas logo
ARVNReportable Segment — R&D
$60.3M-33.6%

Other financials

Income statement

See full
Revenue$31.5M+3.3%
Gross profit$20.0M+3.3%
Operating income$1.6M-67.0%
Net income$6.3M+24.8%
EPS (diluted)$0.07+16.7%

Balance sheet

See full
Cash & equivalents$66.5M+19.7%
Total debt$2.6M-26.9%
Total equity$82.3M+48.8%
Total assets$114.3M+40.6%

Cash flow

See full
Operating cash flow-$1.2M-115%

Valuation

See full
Market cap$254.07M-74.9%
Enterprise value$190.09M-79.7%
P/E13.6×-43.5×
P/S-6.8×

Profitability

See full
Gross margin64.3%+1.8pp
Operating margin10%-2.2pp
Net margin14.3%+1.2pp
FCF margin-70.4%

Returns & leverage

See full
Return on equity27.1%-6.4pp
Debt / equity0.0×
Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's analytical reference standards and services segment — r&d.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NAGE's analytical reference standards and services segment — R&D?
NAGE (NAGE) reported analytical reference standards and services segment — R&D of $0 in Q1 2026.
What does analytical reference standards and services segment — R&D mean?
Represents the capital or operational investment in innovation, product improvement, and the development of new analytical standards within the segment. It is a critical indicator of the segment's commitment to maintaining a competitive technological edge.